Dipeptidyl peptidase IV contributes to the pathogenesis of Cryptococcus neoformans.

Cryptococcus neoformans relies on surface-associated Dpp4 enzyme for virulence, with deletion reducing pathogenicity and delaying host mortality in animal models.

• Why it matters: Cryptococcosis causes severe disease especially in immunocompromised individuals, and current treatments are limited, highlighting the need for novel therapeutic targets.
• What they did: The study investigated cryptococcal Dpp4 by creating gene deletions and assessing enzyme activity, proteomic changes, and infection outcomes in Galleria mellonella and mice, revealing Dpp4's role in pathogenicity.
• The result: Loss of Dpp4 decreased fungal virulence, impaired dissemination to the brain, and delayed host death, suggesting that targeting Dpp4 offers a promising new approach for antifungal therapy.